Anna Luo, Amanda Oakley, Dug Yeo Han, Paul Jarrett
{"title":"Health Equity and Secukinumab for Severe Psoriasis in New Zealand","authors":"Anna Luo, Amanda Oakley, Dug Yeo Han, Paul Jarrett","doi":"10.1111/ajd.14539","DOIUrl":"10.1111/ajd.14539","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background/Objectives</h3>\u0000 \u0000 <p>The only funded indication in New Zealand between October 2018 and April 2021 for the biologic secukinumab, an interleukin-17A antibody, was severe psoriasis. This unique period of limited availability of secukinumab allowed the evaluation of who received it and health equity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Anonymised dispensing data were obtained from the New Zealand Ministry of Health and matched with the New Zealand deprivation index, ethnicity and census data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Compared to the most socio-economically deprived, the least deprived were significantly more likely to receive secukinumab, respectively, dispensing rates per 100,000 (95% confidence interval) 4.00 (3.29–4.71) and 6.56 (5.61–7.51) <i>p</i> < 0.0001. Compared to European ethnicity, Māori, Pacific peoples and Asian were less likely to receive secukinumab, respectively, dispensing rates per 100,000 (95% confidence interval) 6.30 (5.81–6.79), 3.27 (2.56–3.99), 3.31 (2.28–4.33), 4.33 (3.48–5.19) <i>p</i> < 0.0001 all groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Between October 2018 and April 2021, the data suggest that the dispensing of secukinumab was inequitable. Those having severe psoriasis and being socio-economically disadvantaged or of Māori, Pacific and Asian compared to European ethnicity, were significantly less likely to have received secukinumab. Dermatologist workforce shortages in New Zealand are likely to compound the problem.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"e342-e345"},"PeriodicalIF":1.8,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajd.14539","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Annika Smith, Belinda Lai, Clara K. Chow, Sarah Zaman
{"title":"Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice","authors":"Annika Smith, Belinda Lai, Clara K. Chow, Sarah Zaman","doi":"10.1111/ajd.14528","DOIUrl":"10.1111/ajd.14528","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Study Aims</h3>\u0000 \u0000 <p>Patient perspectives on psoriasis as a systemic disease, with its heightened risk of cardiovascular disease (CVD), are unclear. Approaches to cardiovascular risk factor screening and management vary in this cohort. This study aimed to ascertain knowledge, practice and perceptions of patients with respect to psoriasis and CVD, CV risk factor screening and management.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This cross-sectional study consisted of a self-administered questionnaire capturing demographic characteristics, knowledge of the association between psoriasis and CVD, and perspectives on cardiovascular risk factor screening and management. This was distributed to psoriasis patients in public and private clinic settings. The survey data was assessed with the use of descriptive statistics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 102 patients with psoriasis were surveyed. The majority of respondents were male 52%, (53/102), 46–60 years old 30.4% (31/102), with longstanding psoriasis (> 20 years), 42.2.% (43/102). Most patients nominated a dermatologist in a public hospital setting as the primary clinician responsible for their psoriasis management 71.6% (73/102). A total of 20.6% (21/102) psoriasis patients surveyed indicated knowledge of the association between CVD and psoriasis, and 22.5% (23/102) agreed that psoriasis was associated with worse CVD outcomes compared to the general population. 63.7% (65/102) indicated they had undergone CV risk factor screening in the last year, with most nominating general practitioners (GPs) 38.4% (38/99), followed by cardiologists 14.1% (14/99), then dermatologists 9.1% (9/99), as the clinician who performed this CV RF screening. A total of 68.6% (70/102) responded they did not currently have a treating cardiologist, while 34.3% (35/102) nominated a Cardiologist as their preferred clinician to facilitate CVD risk factor screening/management, 23.5% (24/102) indicated a preference for a multidisciplinary team, 17.6% (18/102) nominated GPs and 6.9% (7/102) nominated the dermatologist.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>There is a need for improved patient education regarding the relationship between psoriasis and CVD. Heightened awareness around cardiovascular risk may serve as an impetus for patients to seek relevant cardiovascular risk factor screening, management and pursue healthy lifestyle behaviours.</p>\u0000 </section>\u0000 </div>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 6","pages":"338-343"},"PeriodicalIF":1.8,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ajd.14528","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144198182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Grace Xiong, Eric McMullen, Christopher Shenouda, Sana Gupta, Michal Moshkovich, Joy Soliman, Ilya Mukovozov, Shireen Dumont, Narachai Julanon, Raed Alhusayen, Vincent Piguet
{"title":"Quality and Readability of Online Health Resources for Hidradenitis Suppurativa: A Cross-Sectional Analysis.","authors":"Grace Xiong, Eric McMullen, Christopher Shenouda, Sana Gupta, Michal Moshkovich, Joy Soliman, Ilya Mukovozov, Shireen Dumont, Narachai Julanon, Raed Alhusayen, Vincent Piguet","doi":"10.1111/ajd.14533","DOIUrl":"10.1111/ajd.14533","url":null,"abstract":"<p><p>Hidradenitis suppurativa (HS) or acne inversa is a chronic inflammatory skin condition characterised by painful nodules that significantly diminish quality of life. Patients diagnosed with HS commonly utilise online resources to gain insight into their condition. This study aimed to assess the readability, quality and relevance of 115 online HS resources found via Google. It was found that most of the websites exceeded the recommended 6th-grade reading level, with the average being around the 11th-grade level. JAMA and DISCERN criteria were used to assess the quality of the resources, which revealed limited reliability and timeliness. Our findings emphasise the need for accessible, high-quality, and up-to-date online resources to support informed decision-making for HS patients and promote prompt medical care.</p>","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":1.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12334800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144186423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Paediatric and Adolescent Dermatology","authors":"","doi":"10.1111/ajd.14509","DOIUrl":"https://doi.org/10.1111/ajd.14509","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 S1","pages":"86-91"},"PeriodicalIF":2.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hair and Nails","authors":"","doi":"10.1111/ajd.14502","DOIUrl":"https://doi.org/10.1111/ajd.14502","url":null,"abstract":"","PeriodicalId":8638,"journal":{"name":"Australasian Journal of Dermatology","volume":"66 S1","pages":"40-42"},"PeriodicalIF":2.2,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
